Navigation Links
Tripolar® Cutting Forceps

ProductsTripolar® Cutting Forceps
Company GYRUS ACMI
Item Tripolar® Cutting Forceps
Features 
  • Multifunctional
  • Bipolar modality
  • Variety of sizes
Description This multiple-function instrument allows the surgeon to grasp, coagulate, and transect tissue with a single instrument, eliminating the need for multiple instruments and, in some procedures, costly linear stapling devices.
Info GYRUS ACMI
Customer Service: (508) 804-2600
Web site: http://www.acmicorp.com

Related medicine products :

1. Tanne Corneal Cutting Block
2. Cutting Burr with Dental Shank
3. Cutting Balloon Ultra2 Over-the-Wire Platform
4. Cutting Balloon Ultra2 Monorail Platform
5. Iowa P.K. Press: Cutting Block
6. Side Cutting Cystotome
7. Kleinert-Kutz Bone-Cutting Rongeur
8. C-Max™ Cutting Loop Electrodes
9. Flextome Cutting Balloon Device
10. Zebra 105SL Cutting Edge Barcode Printer Network Connectivity
11. Ostrum Antrum Punch Forceps
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field.
Hydragel K20 is Sebia's quality line of manual agarose gel electrophoresis products. Samples are applied utilizing the same patented applicator combs that is used for sample application on the HYDRAS
Eliminating the need for any manual pipetting, the HydraPLUS delivers precise micro-volumes of sample directly from primary tubes to four HYDRASYS sample applicators contained in a built-in humidity
Handheld Digital Retinal Camera
Medicine Products:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
... given us adequate reasons to make fish a part of ...popular component in fish has always hogged the sp...es conducted by Dutch researchers suggest that Ome...nst age-connected cognitive-decline. During the s...
...ement could make the aggrieved die from a broken h...hat sections in the brain in charge of memory, lea...people who are grieving. They say that important r...a negative loop which could cause heart rhythms to...
...responds to injury has found vulnerabilities simil...ied at least one significant difference. In an a...r the first time that parts of the developing brai...amate, a nervous system messenger compound. Glutam...
...e National Institute of Mental Health and Neuro Sc...strong plea for all out nationwide efforts to dete...have suggested that doctors working at primary hea...ls be educated to identify Parkinsonism and refer ...
Other Medicine News:Health News:Different Approach Needed to Protect Brains of Premature Babies 2Health News:Different Approach Needed to Protect Brains of Premature Babies 3Health News:Make Treatment of Parkinsons More Affordable, Doctors Plead 2Health News:Make Treatment of Parkinsons More Affordable, Doctors Plead 3
(Date:9/5/2008)...Newswire-USNewswire/ -- The Florida,Technology, Re...ida,Atlantic University researcher Dr. Herbert Wei...e Center for Molecular Biology and,Biotechnology i...HS,Resources LLC (CHS), $184,294 as part of the St...ce Grant program (SURECAG). SURECAG was,establishe...
(Date:9/5/2008)...ire-FirstCall/ -- CEL-SCI Corporation,(Amex: CVM ... arthritis data,at the Marcus Evans conference on ...y Dr. Daniel Zimmerman, Senior Vice President of R...that CEL-SCI,s rheumatoid,arthritis vaccine CEL-20...,caused by rheumatoid arthritis in an animal model...
(Date:9/5/2008)...RNewswire-USNewswire/ -- A team of,researchers at ...rants from,India and Pakistan take on the habits o... prostate cancer among male immigrants and breast ...e cancer develop due to many reasons, but,environm...hese cancers,",said Jame Abraham, M.D., medical di...
(Date:9/4/2008)... /- Cytopia Limited (ASX:,CYT) today ...Phase Ib/II,study of CYT997, the company,s novel v...ith an aggressive form of brain cancer known as gl...ial is the first Phase II efficacy study in highly... and the second in its,suite of Phase II studies d...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 1EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 2EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 3New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 1New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 2New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 3New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 4New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 5Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 1Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 2Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 3Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 4Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 5Par Pharmaceutical Reports First Quarter 2008 Results 18874 1Par Pharmaceutical Reports First Quarter 2008 Results 18874 2Par Pharmaceutical Reports First Quarter 2008 Results 18874 3Par Pharmaceutical Reports First Quarter 2008 Results 18874 4Par Pharmaceutical Reports First Quarter 2008 Results 18874 5Par Pharmaceutical Reports First Quarter 2008 Results 18874 6Par Pharmaceutical Reports First Quarter 2008 Results 18874 7Par Pharmaceutical Reports First Quarter 2008 Results 18874 8Par Pharmaceutical Reports First Quarter 2008 Results 18874 9Par Pharmaceutical Reports First Quarter 2008 Results 18874 10Par Pharmaceutical Reports First Quarter 2008 Results 18874 11Par Pharmaceutical Reports First Quarter 2008 Results 18874 12